Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
Neural Regulation01:37

Neural Regulation

43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K
Brainstem01:19

Brainstem

5.8K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
5.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity.

Breast cancer (Dove Medical Press)·2026
Same author

CCR2 Enhances Anti-Intracellular Bacterial Infection by Modulating Macrophage Pyroptosis to Rebalance Th Immune Responses.

Microorganisms·2026
Same author

Human-associated microbial inputs and bacterial-fungal ecological coupling shape antibiotic resistance risk in environmental dust.

Journal of hazardous materials·2026
Same author

Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation.

PLoS pathogens·2026
Same author

Targeting Hyaluronan Signaling Overcomes Primary Effusion Lymphoma Cells Resistance to Rapamycin.

Biological procedures online·2026
Same author

Systematic Review of IgA Nephropathy Coexisting With Alport Syndrome.

Kidney international reports·2026

相关实验视频

Updated: Jan 18, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K

关于帕金森病的最新信息

Hong Bai1, Wenhui Ma2, Lei Zhu1

  • 1Department of Neurology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.

Neuropsychiatric disease and treatment
|September 10, 2025
PubMed
概括
此摘要是机器生成的。

帕金森病的研究表明,针对α-synuclein和LRRK2的新诊断工具和疗法提供了希望. 神经调节和数字表型学的进步改善了患者护理和运动波动的预测.

关键词:
帕金森病是帕金森氏症的一种疾病.生物标志物 生物标志物深度大脑刺激 刺激大脑改变疾病的疗法.基因与环境的相互作用.线粒体功能障碍 线粒体功能障碍精准医学是一门精准医学.α-同核素的传播

更多相关视频

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.0K

相关实验视频

Last Updated: Jan 18, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.0K

科学领域:

  • 神经退行性疾病的神经退行性疾病
  • 帕金森病的发病因子
  • 肠-大脑轴的机制

背景情况:

  • 帕金森病 (PD) 是一种进展性神经退行性疾病,其全球影响越来越大.
  • 机械学研究涉及阿尔法-同核素传播,线粒体功能障碍和神经炎症在PD.
  • 遗传和环境因素相互作用,推动疾病的进展.

研究的目的:

  • 审查最近在帕金森病诊断和治疗方面的进展.
  • 突出生物标志物验证和非运动性症状管理的新兴解决方案.
  • 为了强调向PD精确准干预的转变.

主要方法:

  • 阿尔法同核素种子放大试验与多式联络神经成像相结合.
  • 对α-synuclein免疫疗法和LRRK2激酶抑制剂的II期临床试验.
  • 开发闭环深度大脑刺激系统和可穿戴的数字表型设计.
  • 应用单细胞空间转录组学来识别神经元的脆弱性.

主要成果:

  • 使用组合测试,对前发性帕金森病的诊断准确率为92%.
  • 阿尔法同核素免疫疗法显示,运动衰退减少了40%.
  • LRRK2 抑制剂证明了血脑屏障的透.
  • 闭环深度大脑刺激提供了63%的优异症状控制.
  • 数字表型化实现了89%的运动波动预测准确度.

结论:

  • 目前的研究促进了从症状治疗到精确向性干预治疗帕金森病的过渡.
  • 跨不同族群的生物标志物验证和非运动性症状的管理仍然是关键的挑战.
  • 新兴技术为改善PD诊断,监测和治疗提供了巨大的潜力.